Innovative Targeted and Immune-Mediated Cancer Therapies
Pipeline
Developing first-in-class small molecule product candidates with broad potential benefit to patients
Science
Modulating validated and new pathways to develop novel therapeutics
News
December 1,
2023
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 20,
2023
Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference
November 8,
2023
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
Events
Tuesday,
November 28TH,
2023
at
3:00 PM
Eastern
35th Annual Piper Sandler Healthcare Conference
Listen: Webcast
Wednesday,
October 11TH,
2023
at
8:30 AM
Eastern
TPST-1120 Global Randomized Phase 1b/2 Combination Study Data Call
Listen: Webcast
Download: Presentation [pdf]
Monday,
September 11TH,
2023
at
7:00 AM
Eastern
H.C. Wainwright 25th Annual Global Investment Conference
Listen: Webcast